GC

IR Information

GREAT
COMPANY

Towards Corporate Value of 50 Trillion
in 2030

Stock Status

As a global leader in the health industry,
we are increasing corporate value
across various business areas

Total Number of Shares [as of the end of 2017]Unit: Number of shares

Total Number of Shares1
Type	Common stock	Preferred stock	Total
Total issued	47,028,210	2,514,860	49,543,070
Treasury stock	2,094,020	2,047,319	4,141,339
In circulation	44,934,190	467,541	45,401,731

Total Number of Shares 2
Type	Stock Type	FY2020	FY2019	FY2018
Face price per share (KRW)		500	500	500
(Consolidated) net income (in KRW million)		170,960	2,957	18,467
(Separate) net income (in KRW million)		50,376	28,053	19,511
(Consolidated) net income per share (KRW)*		3,793	60	406
Total payout in cash (in KRW million)		22,702	14,757	11,352
(Consolidated) propensity to cash payout (%)		13.3	498.9	61.5
Cash dividend yield ratio (%)	Common stock	1.4	1.5	1.0
Cash dividend yield ratio (%)	Preferred stock	-	-	-
Weekly Cash dividend ratio (KRW)	Common stock	500	325	250
Weekly Cash dividend ratio (KRW)	Preferred stock	505	330	255

*This amount includes discontinued operations.

Summary Consolidated Income Statement Unit: KRW million

Summary Consolidated Income Statement
Type	2021	2020	2019
Sales	1,840,559	1,719,326	1,493,589
Operating Profit	86,244	70,732	66,745
Net Income Before Income Tax Expenses	180,013	107,919	26,307
Net Income	127,658	179,995	-30,477
Total Comprehensive Income	155,208	184,695	-28,282

Summary Consolidated Statement of Financial Position Unit: KRW million

신용등급 ※ 회사채 신용평가는 매년 1회 정기평가를 받고 있습니다

신용등급 표
구분	한국기업평가	신용등급	A+ (2020년)
구분	NICE 신용평가	신용등급	AA- (2020년)